Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-23

FDA Approved: DEPO-SUBQ PROVERA — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for DEPO-SUBQ PROVERA (medroxyprogesterone acetate) from Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE)

Snippet

SUPPL AP for DEPO-SUBQ PROVERA (MEDROXYPROGESTERONE ACETATE)